Diurnal Group PLC Fundraise



We are delighted to have acted as nominated adviser, corporate broker and sole bookrunner for Diurnal Group plc’s successful £9.79 million fundraising. The funds will be used to continue to support the development of DITEST™, the early stage pipeline and commencement of Phase 3 preparation activities for Chronocort® in the US and preparation for Alkindi® and Chronocort® in Japan.

Other insights like this

View all